Generic cancer drug reimbursement
Kevin Outterson August 8, 2011
Tyler gives high marks to Ezekiel Emanuel’s Opinion in the NYT on reimbursement problems for generic Part B cancer drugs,* leading to shortages. Emanuel describes
Tyler gives high marks to Ezekiel Emanuel’s Opinion in the NYT on reimbursement problems for generic Part B cancer drugs,* leading to shortages. Emanuel describes
I got my usual slew of email after I suggested that the super committee could at least talk about a single-payer health care system. Emails
Still getting pushback on my assertion that fixing the SGR isn’t really deficit reducing. David Nanther, in a very amusing Politico piece on how the
Igor Volsky shares Politico Pro’s David Nather’s list of potential savings in Medicare for the Super Committee to consider. It’s worth a look. I have no
I’ve long thought, and often said, that to have good health is one’s most important asset. Do you agree with me? I bet most do.
Work posted here under copyright © of the authors • Details on the Site Policies page
